News
BIO-B
326.74
0.00%
0.00
Weekly Report: what happened at BIO B last week (0902-0906)?
Weekly Report · 4d ago
Bio Rad Laborato: Report of proposed sale of securities
Press release · 09/05 00:39
Weekly Report: what happened at BIO B last week (0826-0830)?
Weekly Report · 09/02 09:05
Bio Rad Laborato: Statement of changes in beneficial ownership of securities
Press release · 08/29 00:18
Weekly Report: what happened at BIO B last week (0819-0823)?
Weekly Report · 08/26 09:05
Weekly Report: what happened at BIO B last week (0812-0816)?
Weekly Report · 08/19 09:05
Weekly Report: what happened at BIO B last week (0805-0809)?
Weekly Report · 08/12 09:05
Weekly Report: what happened at BIO B last week (0729-0802)?
Weekly Report · 08/05 09:05
Weekly Report: what happened at BIO B last week (0722-0726)?
Weekly Report · 07/29 09:05
Weekly Report: what happened at BIO B last week (0715-0719)?
Weekly Report · 07/22 09:05
Weekly Report: what happened at BIO B last week (0708-0712)?
Weekly Report · 07/15 09:05
Weekly Report: what happened at BIO B last week (0701-0705)?
Weekly Report · 07/08 09:05
Weekly Report: what happened at BIO B last week (0624-0628)?
Weekly Report · 07/01 09:05
Weekly Report: what happened at BIO B last week (0617-0621)?
Weekly Report · 06/24 09:05
Weekly Report: what happened at BIO B last week (0610-0614)?
Weekly Report · 06/17 09:05
Weekly Report: what happened at BIO B last week (0603-0607)?
Weekly Report · 06/10 09:05
Weekly Report: what happened at BIO B last week (0527-0531)?
Weekly Report · 06/03 09:05
Weekly Report: what happened at BIO B last week (0520-0524)?
Weekly Report · 05/27 09:05
Weekly Report: what happened at BIO B last week (0513-0517)?
Weekly Report · 05/20 09:05
Weekly Report: what happened at BIO B last week (0506-0510)?
Weekly Report · 05/13 09:05
More
Webull provides a variety of real-time BIO-B stock news. You can receive the latest news about Bio Rad Laborato through multiple platforms. This information may help you make smarter investment decisions.
About BIO-B
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. The Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are primarily sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.